Abstract
The INNO LiPA Rif.TB (Innogenetics, Ghent, Belgium) is a reverse hybridization test developed to detect genetic markers of resistance to rifampin in Mycobacterium tuberculosis complex. In the present study, this test was used directly on 3,763 clinical specimens by adopting a nested amplification of the target. The specificity of the system (98.4%) was optimal, but sensitivity (69.5%) was unsatisfactory. However, when use of the system was limited to smear-positive specimens, the sensitivity rose to 91.7%. As expected, the ability of the system to predict rifampin resistance was not influenced by its direct use on clinical specimens and confirmed the favorable results repeatedly reported in the literature.
Similar content being viewed by others
References
World Health Organization (2005) Global tuberculosis programme. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1994–1997. WHO, Geneva, Switzerland, pp 1–153
Pfyffer GE, Brown-Elliott BA, Wallace RJ Jr (2003) Mycobacterium: general characteristics, isolation, and staining procedures. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology. ASM Press, Washington DC, pp 532–559
Cooksey RC (2003) Recent advances in laboratory procedures for pathogenic mycobacteria. Clin Lab Med 23:801–821
Drobniewski FA, Caws M, Gibson A, Young D (2003) Modern laboratory diagnosis of tuberculosis. Lancet Infect Dis 3:141–147
Abe C, Ogata H, Kawata K, Hiraga T, Takashima T, Suetake T (2000) Detection of rifampin-resistant Mycobacterium tuberculosis by line probe assay (LiPA). Kekkaku 75:575–581
Bártfai Z, Somoskövi A, Ködmön C, Szabó N, Puskás E, Kosztolányi L, Faragó E, Mester J, Parsons LM, Salfinger M (2001) Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol 39:3736–3739
Cooksey RC, Morlock GP, Glickman S, Crawford JT (1997) Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol 35:1281–1283
Gamboa F, Cardona PJ, Manterola JM, Lonca J, Matas L, Padilla E, Manzano JR, Ausina V (1998) Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis 17:189–192
Hirano K, Abe C, Takahasci M (1999) Mutations of rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol 37:2663–2666
Johansen IS, Lundgren B, Sosnovskaja A, Thomsen VØ (2003) Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J Clin Microbiol 41:4454–4456
Matsiota-Bernard P, Vrioni G, Marinis E (1998) Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Grece. J Clin Microbiol 36:20–23
Mokrousov I, Filliol I, Legrand E, Sola C, Otten T, Vyshnevskaya E, Limeschenko E, Vyshnevskiy B, Narvskaya O, Rastogi N (2002) Molecular characterization of multiple-drug-resistant Mycobacterium tuberculosis isolates from northwestern Russia and analysis of rifampin resistance using RNA/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpoB gene. Res Microbiol 153:213–219
Watterson SA, Wilson SM, Yates MD, Drobniewski FA (1998) Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 36:1969–1973
Morgan M, Kalantri S, Flores L, Pai M (2005) A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 5:62
Tortoli E, Mariottini A, Mazzarelli G (2003) Evaluation of INNO-LiPA MYCOBACTERIA v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. J Clin Microbiol 41:4418–4420
Richter E, Weizenegger M, Fahr AM, Rüsch-Gerdes S (2004) Usefulness of the GenoType MTBC assay for differentiating species of the Mycobacterium tuberculosis complex in cultures obtained from clinical specimens. J Clin Microbiol 42:4303–4306
Cloud JL, Neal H, Rosenberry R, Turenne CY, Jama M, Hillyard DR, Carroll KC (2002) Identification of Mycobacterium spp. by using a commercial 16S ribosomal DNA sequencing kit and additional sequencing libraries. J Clin Microbiol 40:400–406
Siddiqi SH, Libonati JP, Middlebrook G (1981) Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 13:908–912
Davidoff F (1999) Standing statistic right side up. Ann Intern Med 130:1019–1021
Heifets LB, Cangelosi GA (1999) Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int J Tuberc Lung Dis 3:564–581
World Health Organization (1998) Guidelines for surveillance of drug resistance in tuberculosis. Int J Tuberc Lung Dis 2:72–89
Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A (2002) Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 40:4435–4438
De Beenhouwer H, Lhiang Z, Jannes G, Mijs W, Machtelinckx L, Rossau R, Traore H, Portaels F (1995) Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis 76:425–430
Higuchi T, Fushiwaki T, Tanaka N, Miyake S, Ogura T, Yoshida H, Takashima T, Nakagawa M, Maekura R, Hiraga T, Suetake T (2004) Direct detection of rifampicin resistant Mycobacterium tuberculosis in sputum by line probe assay (LiPA). Kekkaku 79:525–530 (in Japanese)
Viveiros M, Leandro C, Rodrigues L, Almeida J, Bettencourt R, Couto I, Carrilho L, Diogo J, Fonseca A, Lito L, Lopes J, Pacheco T, Pessanha M, Quirim J, Sancho L, Salfinger M, Amaral L (2005) Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J Clin Microbiol 43:4880–4884
Piersimoni C, Scarparo C (2003) Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol 41:5355–5365
Bergmann JS, Woods GL (1996) Clinical evaluation of the Roche AMPLICOR PCR Mycobacterium tuberculosis test for detection of M. tuberculosis in respiratory specimens. J Clin Microbiol 34:1083–1085
Bergmann JS, Keating WE, Woods GL (2000) Clinical evaluation of the BDProbeTec ET system for rapid detection of Mycobacterium tuberculosis. J Clin Microbiol 38:863–865
Reischl U, Lehn N, Wolf H, Naumann L (1998) Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens. J Clin Microbiol 36:2853–2860
Wobeser WL, Krajden M, Conly J, Simpson H, Yim B, D’Costa M, Fuksa M, Hian-Cheong C, Petterson M, Phillips A, Bannatyne R, Haddad A, Brunton JL, Krajden S (1996) Evaluation of Roche Amplicor PCR assay for Mycobacterium tuberculosis. J Clin Microbiol 34:134–139
Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S (2005) Use of the GenoType MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 43:3699–3703
Acknowledgements
We are indebted to M. Coyle who carefully reviewed the manuscript. We thank G. Cecchi and M. Morrisi for technical work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tortoli, E., Marcelli, F. Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility. Eur J Clin Microbiol Infect Dis 26, 51–55 (2007). https://doi.org/10.1007/s10096-006-0240-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-006-0240-x